Cargando…
Inhibition of mTORC1 inhibits lytic replication of Epstein-Barr virus in a cell-type specific manner
BACKGROUND: Epstein-Barr virus is a human herpesvirus that infects a majority of the human population. Primary infection of Epstein-Barr virus (EBV) causes the syndrome infectious mononucleosis. This virus is also associated with several cancers, including Burkitt’s lymphoma, post-transplant lymphop...
Autores principales: | Adamson, Amy L, Le, Brandi T, Siedenburg, Brian D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059732/ https://www.ncbi.nlm.nih.gov/pubmed/24917448 http://dx.doi.org/10.1186/1743-422X-11-110 |
Ejemplares similares
-
Towards specific inhibition of mTORC2
por: Murray, Elizabeth R., et al.
Publicado: (2017) -
Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
por: Gorres, Kelly L., et al.
Publicado: (2016) -
Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
por: Luo, Yan, et al.
Publicado: (2015) -
Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
por: Bilger, Andrea, et al.
Publicado: (2017) -
Replication Compartments—The Great Survival Strategy for Epstein–Barr Virus Lytic Replication
por: Sugimoto, Atsuko
Publicado: (2022)